Literature DB >> 27424519

The Potential of Indole/Indolylquinoline Compounds in Tau Misfolding Reduction by Enhancement of HSPB1.

Kuo-Hsuan Chang1,2, Chih-Hsin Lin1, Hsuan-Chiang Chen3, Hsin-Yu Huang3, Shu-Ling Chen3, Te-Hsien Lin3, Chintakunta Ramesh4, Chin-Chang Huang1, Hon-Chung Fung1, Yih-Ru Wu1, Hei-Jen Huang5, Guey-Jen Lee-Chen3, Hsiu Mei Hsieh-Li3, Ching-Fa Yao4.   

Abstract

BACKGROUND: Neurofibrillary tangles formed from tau misfolding have long been considered one of the pathological hallmarks of Alzheimer's disease (AD). The misfolding of tau in AD correlates with the clinical progression of AD and inhibition or reversal of tau misfolding may protect the affected neurons.
METHODS: We generated 293 and SH-SY5Y cells expressing DsRed-tagged pro-aggregation mutant of repeat domain of tau (ΔK280 tauRD ) to test indole/indolylquinoline derivatives for reducing tau misfolding and neuroprotection.
RESULTS: Four of the 10 derivatives tested displayed good misfolding-inhibitory effects on Tet-On 293 cells. Among them, NC009-1 and NC009-7 enhanced heat-shock 27 kDa protein 1 (HSPB1) expression to increase ∆K280 tauRD -DsRed solubility and promoted neurite outgrowth in Tet-On SH-SY5Y cells. Knockdown of HSPB1 resulted in decreased ∆K280 tauRD -DsRed solubility and reduced neurite outgrowth, which were rescued by addition of NC009-1/NC009-7. Treatment with indole/indolylquinoline derivatives also improved neuronal cell viability and neurite outgrowth in mouse hippocampal primary culture under tau cytotoxicity.
CONCLUSION: Our results demonstrate how indole/indolylquinoline derivatives are likely to work in tau misfolding reduction, providing insight into the possible working mechanism of indole and indolylquinoline derivatives in AD treatment.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; HSPB1; Indole/indolylquinoline compounds; Tau misfolding; Therapeutics

Mesh:

Substances:

Year:  2016        PMID: 27424519      PMCID: PMC6492720          DOI: 10.1111/cns.12592

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  55 in total

Review 1.  Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases.

Authors:  M Y Sherman; A L Goldberg
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

Review 2.  Neurodegenerative tauopathies.

Authors:  V M Lee; M Goedert; J Q Trojanowski
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

3.  Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells.

Authors:  Gerry Shaw; Silas Morse; Miguel Ararat; Frank L Graham
Journal:  FASEB J       Date:  2002-04-10       Impact factor: 5.191

4.  A protein factor essential for microtubule assembly.

Authors:  M D Weingarten; A H Lockwood; S Y Hwo; M W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

Review 5.  Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.

Authors:  Dick Terwel; Ilse Dewachter; Fred Van Leuven
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

6.  Rapid protein-folding assay using green fluorescent protein.

Authors:  G S Waldo; B M Standish; J Berendzen; T C Terwilliger
Journal:  Nat Biotechnol       Date:  1999-07       Impact factor: 54.908

7.  Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.

Authors:  D Denis; D Riendeau
Journal:  Eur J Pharmacol       Date:  1999-02-19       Impact factor: 4.432

Review 8.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

Authors:  L Buée; T Bussière; V Buée-Scherrer; A Delacourte; P R Hof
Journal:  Brain Res Brain Res Rev       Date:  2000-08

9.  Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin.

Authors:  Andreas Wyttenbach; Olivier Sauvageot; Jenny Carmichael; Chantal Diaz-Latoud; Andre-Patrik Arrigo; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2002-05-01       Impact factor: 6.150

10.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.

Authors:  I D'Souza; P Poorkaj; M Hong; D Nochlin; V M Lee; T D Bird; G D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

View more
  8 in total

1.  Novel synthetic chalcone-coumarin hybrid for Aβ aggregation reduction, antioxidation, and neuroprotection.

Authors:  Shin-Ying Lee; Ya-Jen Chiu; Shu-Mei Yang; Chiung-Mei Chen; Chin-Chang Huang; Guey-Jen Lee-Chen; Wenwei Lin; Kuo-Hsuan Chang
Journal:  CNS Neurosci Ther       Date:  2018-09-14       Impact factor: 5.243

2.  In silico-based screen synergistic drug combinations from herb medicines: a case using Cistanche tubulosa.

Authors:  Jianling Liu; Jinglin Zhu; Jun Xue; Zonghui Qin; Fengxia Shen; Jingjing Liu; Xuetong Chen; Xiaogang Li; Ziyin Wu; Wei Xiao; Chunli Zheng; Yonghua Wang
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

3.  Modeling Alzheimer's Disease by Induced Pluripotent Stem Cells Carrying APP D678H Mutation.

Authors:  Kuo-Hsuan Chang; Guey-Jen Lee-Chen; Ching-Chang Huang; Jia-Li Lin; Yi-Jing Chen; Pei-Chi Wei; Yen-Shi Lo; Chin-Fa Yao; Ming-Wei Kuo; Chiung-Mei Chen
Journal:  Mol Neurobiol       Date:  2018-09-20       Impact factor: 5.590

4.  Exploration of multi-target effects of 3-benzoyl-5-hydroxychromen-2-one in Alzheimer's disease cell and mouse models.

Authors:  Te-Hsien Lin; Ya-Jen Chiu; Chih-Hsin Lin; Chung-Yin Lin; Chih-Ying Chao; Yu-Chieh Chen; Shu-Mei Yang; Wenwei Lin; Hsiu Mei Hsieh-Li; Yih-Ru Wu; Kuo-Hsuan Chang; Guey-Jen Lee-Chen; Chiung-Mei Chen
Journal:  Aging Cell       Date:  2020-06-04       Impact factor: 9.304

5.  Flavones 7,8-DHF, Quercetin, and Apigenin Against Tau Toxicity via Activation of TRKB Signaling in ΔK280 TauRD-DsRed SH-SY5Y Cells.

Authors:  Ni-Ni Chiang; Te-Hsien Lin; Yu-Shan Teng; Ying-Chieh Sun; Kuo-Hsuan Chang; Chung-Yin Lin; Hsiu Mei Hsieh-Li; Ming-Tsan Su; Chiung-Mei Chen; Guey-Jen Lee-Chen
Journal:  Front Aging Neurosci       Date:  2021-12-15       Impact factor: 5.750

6.  Novel Synthetic Coumarin-Chalcone Derivative (E)-3-(3-(4-(Dimethylamino)Phenyl)Acryloyl)-4-Hydroxy-2H-Chromen-2-One Activates CREB-Mediated Neuroprotection in Aβ and Tau Cell Models of Alzheimer's Disease.

Authors:  Ya-Jen Chiu; Te-Hsien Lin; Chiung-Mei Chen; Chih-Hsin Lin; Yu-Shan Teng; Chung-Yin Lin; Ying-Chieh Sun; Hsiu Mei Hsieh-Li; Ming-Tsan Su; Guey-Jen Lee-Chen; Wenwei Lin; Kuo-Hsuan Chang
Journal:  Oxid Med Cell Longev       Date:  2021-11-13       Impact factor: 6.543

Review 7.  The Role of Small Heat Shock Proteins in Protein Misfolding Associated Motoneuron Diseases.

Authors:  Barbara Tedesco; Veronica Ferrari; Marta Cozzi; Marta Chierichetti; Elena Casarotto; Paola Pramaggiore; Francesco Mina; Mariarita Galbiati; Paola Rusmini; Valeria Crippa; Riccardo Cristofani; Angelo Poletti
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

8.  Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation.

Authors:  Ya-Jen Chiu; Shu-An Lin; Wan-Ling Chen; Te-Hsien Lin; Chih-Hsin Lin; Ching-Fa Yao; Wenwei Lin; Yih-Ru Wu; Kuo-Hsuan Chang; Guey-Jen Lee-Chen; Chiung-Mei Chen
Journal:  Aging (Albany NY)       Date:  2020-11-10       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.